Objectives: Body mass index (BMI) commonly is used in obesity classification as a surrogate measure, and obesity is associated with a cluster of risk factors for cardiovascular disease. The aim of this study was to investigate the impact of BMI on short-term outcomes after cardiac surgery.
B
ODY MASS INDEX (BMI) is a person's weight in kilograms divided by the square of height in meters and commonly is used in obesity classification as a surrogate measure. A BMI value of Z30 kg/m 2 defines obesity, and a BMI value of 25 to 29.9 kg/m 2 defines being overweight. 1, 2 Obesity is associated with a cluster of risk factors for cardiovascular disease, known as the metabolic syndrome, which include hypertension, dyslipidemia, insulin resistance, and diabetes mellitus. 2, 3 The prevalence of obesity worldwide, especially in developed countries, has reached epidemic proportions. It is expected that an increasing number of obese patients will require cardiac surgery. 4 Even though not always accurate, BMI still is a useful measure of overall body habitus because it is highly correlated with body surface area 5 ; it also commonly is used in anthropometric measurements in most previous and new risk models for the Society of Thoracic Surgeons (STS). [5] [6] [7] Several studies have examined the effects of obesity on inhospital mortality and long-term survival with variable conclusions. Some studies have suggested that obesity does not increase morbidity or mortality but actually is associated with favorable outcomes after cardiac surgery, [8] [9] [10] [11] whereas other studies have demonstrated that obesity is a predictor of either morbidity or mortality. [12] [13] [14] [15] [16] [17] Because the relationship between BMI and surgical outcomes is complex, the aim of the study presented here was to evaluate the influence of BMI on early clinical outcomes in patients undergoing cardiac surgery.
METHODS

Study Design
This was a 2-center study involving 6,515 patients who underwent cardiac surgery at 2 hospitals, with the period in 1 hospital spanning from July 1, 2001 , to June 30, 2013 , and in the other hospital from September 1, 2003 , to August 31, 2014. Institutional review board permissions of the 2 hospitals were granted for this retrospective study. Patients included in the study met the following criteria: coronary artery bypass grafting (CABG) and/or valve surgery and CABG and/or valve surgery combined with other procedures. Patients excluded from the study met 1 of the following criteria: emergency surgery, off-pump or robotic surgery, surgery requiring deep hypothermic circulatory arrest or involving the thoracic aorta, and patients with incomplete data. A total of 4,740 patients met the inclusion criteria and were assigned into the following 6 classes according to their BMI: underweight (BMI o18.5 kg/m 2 ; n = 62), normal weight (Z18.5 to o25 kg/m 2 ; n = 1,144), overweight (Z25 to o30 kg/m 2 ; n = 1,774), class I obese (Z30 to o35 kg/m 2 ; n = 1,044), class II obese (Z35 to o40 kg/m 2 ; n = 441), and class III obese (BMI Z40 kg/m 2 ; n = 275). 18 The study design is shown in Figure 1 .
Data Collection
Patient data from 2 hospitals' medical records were both collected and organized following the template of the STS Adult Cardiac Surgery Database Data Specifications (version 2.81, 2014) and included demographics, patient history, medical record information, preoperative risk factors, preoperative medications, intraoperative variables, postoperative events, in-hospital mortality, 30-day mortality, and surgical mortality.
Outcome Definitions
Primary outcomes were in-hospital mortality, 30-day mortality, surgical mortality, and life-threatening cardiovascular events, including postoperative stroke, cardiac arrest, new atrial fibrillation/flutter, and permanent rhythm device insertion. Secondary outcomes included deep sternal infection, sepsis, prolonged ventilation, pneumonia, renal dialysis, renal failure, intensive care unit (ICU) readmission, total ICU hours, and readmission in 30 days.
The definitions of all these outcomes were based on the STS Adult Cardiac Surgery Database Data Specifications. Primary outcome definitions were as follows: in-hospital mortalitydeath during the hospitalization in which surgery occurred; 30-day mortality-death at 30 days after surgery (whether or not occurring in hospital); surgical mortality-(1) all deaths, regardless of cause, occurring during the hospitalization period in which the surgery was performed, even if after 30 days (including patients transferred to other acute care facilities), and (2) all deaths, regardless of cause, occurring after discharge from the hospital but before the end of the 30th postoperative day; stroke-the patient experiencing a postoperative stroke and the type of stroke (ie, any confirmed neurologic deficit of abrupt onset caused by a disturbance in blood supply to the brain) that did not resolve within 24 hours; cardiac arrest-the patient experiencing acute cardiac arrest documented by 1 of the 4 following diagnoses: ventricular fibrillation, rapid ventricular tachycardia with hemodynamic instability, asystole, and implantable cardioverter-defibrillator shocks; new atrial fibrillation/flutter (AF)-the patient experiencing AF requiring treatment (excluding AF at the start of surgery); and permanent device insertion-the patient developing new arrhythmia requiring insertion of a permanent device. Secondary outcomes definitions are as follows: deep sternal infection-a deep sternal wound infection or mediastinitis within 30 days of the procedure or any time during the hospitalization for surgery; sepsis-evidence of serious infection accompanied by a deleterious systemic response; prolonged ventilation-the patient experiencing prolonged postoperative pulmonary ventilation (424 hours); pneumonia-the patient experiencing pneumonia according to the Centers for Disease Control definition; renal dialysis-the patient having a new requirement for dialysis postoperatively, which could include hemodialysis and peritoneal dialysis; renal failure-the patient experiencing acute renal failure or worsening renal function resulting in 1 or both of the following criteria: (1) increase in serum creatinine level 3 times greater than the baseline or serum creatinine level Z4 mg/dL (acute rise must be at least 0.5 mg/d) and/or 
IMPACT OF BODY MASS INDEX
(2) a new requirement for dialysis postoperatively; ICU readmission-whether the patient spent time in an ICU after having been transferred to a step-down unit (total ICU hours was the summation of initial ICU hours and additional ICU hours); and readmission in 30 days-indicates whether the patient was readmitted for any reason to an acute-care facility as an in-patient within 30 days from the date of the initial surgery.
Statistical Analysis
SAS version 9.4 for Windows (SAS Institute, Cary, NC) was used for statistical analysis. BMI group categorical variables were compared using the chi-square test and are presented as numbers and percentages. Continuous variables were compared using t-test analysis and are presented as mean Ϯ standard deviation. Univariate and multivariate logistic regressions were performed to assess associations of demographic and preoperative risk factors and clinical outcome variables.
Parsimonious multivariate logistic regression and multivariable general linear analysis adjusted with patient demographic and clinical risk factors were performed to investigate the effect of BMI on short-term outcomes (categorical and continuous variables, respectively). To achieve model parsimony and stability, the backward selection procedure was applied with the drop-out criterion p 4 0.05 from risk factors on the basis of variables collected in the database, forced inclusion of BMI, surgery type, age, sex, and status. The results are reported as numbers with percentages, mean Ϯ SD, and odds ratios (OR) with 95% confidence intervals (CI). All reported p values are 2-tailed, and p values o0.05 were considered to be statistically significant. Table 1 demonstrates demographic data, the preoperative risk profile, and procedural characteristics of all groups. Patients in the normal weight group were the oldest (64.9 Ϯ 13.5) among Postoperative Outcomes Table 2 shows unadjusted short-term postoperative outcomes of all BMI groups. The incidence of sternal infection in the class III obese group was much higher than that of the normal weight group (p ¼ 0.002). Class III obese and underweight patients tended to have prolonged ventilation hours after surgery (p ¼ 0.001). Furthermore, more patients in the class III obese group required dialysis postoperatively (p ¼ 0.01). Class III obese and underweight groups experienced significantly greater in-hospital mortality (p ¼ 0.004), 30-day mortality (p ¼ 0.042), surgical mortality (p ¼ 0.033), and patient readmission within 30 days (p ¼ 0.005) than the other groups. 
RESULTS
Baseline and Intraoperative Characteristics
DISCUSSION
Obesity is a risk factor for diabetes mellitus, hypertension, and cardiovascular diseases. Obesity accounts for a large proportion (37.1% in this study) of the population undergoing cardiac surgery. Previous studies have shown that extremely obese or underweight patients have increased risks for some early major complications, such as deep sternal infection, 11, 13 prolonged ventilation, 14,19 and renal failure 13 ; however, patients who are either overweight or mildly obese may have a lower in-hospital and surgical mortality. [8] [9] [10] [11] Findings of this study demonstrated that there were higher rates of deep sternal infection, renal dialysis, and renal failure in class III obese patients, increased prolonged ventilation in class III obese and underweight patients, and increased new atrial fibrillation/ flutter in class II obese and underweight patients. On the other hand, although extreme obesity increased the rate of readmission within 30 days, patients who were either overweight or mildly obese experienced significantly decreased in-hospital mortality, surgical mortality, and total time spent in the ICU.
BMI and Preoperative Profiles
Similar to other published results, 19 -21 the preoperative characteristics of patients in this cohort showed that obese patients were more likely to be younger, male, and have diabetes and hypertension compared with normal weight BMI patients. They also were more likely to have a significantly increased family history of coronary artery disease, experience moderate or severe chronic lung disease, and use lipid-lowering medication. More overweight and obese patients had experienced previous percutaneous coronary interventions than had the other groups. These findings implied that obese patients tend to develop coronary artery disease earlier and undergo surgical revascularization at a younger age, likely because of the higher risks of diabetes, hypertension, hyperlipidemia, and family history of coronary disease.
BMI and Early Outcomes
In this study, with and without risk adjustment, earlier postoperative outcomes demonstrated the incidence of deep sternal infection in class III obese patients as being significantly higher than in the other groups, which corresponded to a previous study. 22 This indicated an association between obesity and deep sternal infection; therefore, extreme obesity (BMI Z40 kg/m 2 ) could be identified as an independent risk factor for deep sternal infection after cardiac surgery. Likewise, patients in both the class III obese and underweight groups experienced prolonged ventilation after cardiac surgery compared with the normal weight group with or without risk adjustment. After general anesthesia and during the immediate postoperative period, morbidly obese patients were more likely to have significant impairments of pulmonary gas exchange and respiratory mechanics due to the patients already having experienced severe alterations of their respiratory mechanics, such as decreased chest wall and lung compliance and decreased functional residual capacity. Eichenberger et al found that general anesthesia in morbidly obese (BMI 435 kg/m 2 ) patients generated much more atelectasis than in nonobese patients. 23 This explained why in the cohort study presented here that patients with a BMI 440 kg/m 2 experienced a higher incidence of prolonged ventilation. The finding presented here for underweight patients was consistent with the finding of Potapov et al in that cachectic patients (BMI o18.5 kg/m 2 ) demonstrated significantly more complications compared with the overall study population. 24 The authors suggested that poor nutrition status led to less reserves, which may make it difficult for cachectic patients to handle surgical stress and postoperative complications efficiently. 21 These facts suggested that low BMI may be a surrogate marker for comorbidities and stratification of perioperative risks; patients with low body weight, especially cachectic patients, also should be given the same considerations as those for obese patients when surgical and postoperative risk factors are assessed.
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In the study presented here, there was a significant increase in the incidence of postoperative atrial fibrillation/flutter in both the class II obese and underweight groups after risk factor adjustment using parsimonious multivariable logistic regression. This finding was similar to the finding from the study by Kuduvalli et al involving 4 ,713 patients that demonstrated obesity as a risk factor for atrial arrhythmia.
25
There was a significant increase in postoperative renal dialysis requirement in both the class III obese and underweight groups compared with the normal weight group in the original observed outcomes. After risk factor adjustment, only class III obese patients experienced significantly higher rates of postoperative renal dialysis and renal failure. The links between obesity and the development of chronic kidney disease have been known for several years, but the association with acute kidney injury is less clear.
26,27 A study suggested that visceral adipose tissue, through secreted hormones and cytokines coupled with insulin resistance and hyperinsulinemia in obese patients, could lead to inappropriate activation of the reninangiotensin-aldosterone axis and increased oxidative stress in the kidneys. 28 Even though it is widely accepted that obesity increases the risk of heart disease, a growing number of recent reports have documented a significant survival benefit in obese patients once they have been diagnosed. This has been called "obesity paradox," which was demonstrated in the study presented here in that both the class III obese and underweight groups experienced significantly higher short-term postoperative mortality (in-hospital mortality, 30-day mortality, and surgical mortality) and 30-day readmission rates, but, after risk factor adjustment, there was a statistically significant benefit to inhospital mortality and surgical mortality in just the mildly obese (class I) group (see Table 3 ). Furthermore, there was significantly shorter total ICU stay in the overweight and class I obese groups. The data indicated that mild obesity could decrease short-term postoperative mortality, which was consistent with previous studies that postulated the existence of an obesity paradox in a mixed cardiac surgical population in terms of in-hospital outcomes and mortality. [29] [30] [31] [32] [33] This beneficial effect may be related to the lower systemic vascular resistance and plasma renin activity of obese patients compared with leaner patients. 34 In addition, overweight and obese patients have lower levels of circulating atrial natriuretic peptides, attenuated sympathetic nervous systems, and reninangiotensin responses. 35, 36 It is plausible that patients who are overweight may have the necessary metabolic reserves to overcome the further increased catabolic stress resulting from a stressful surgery. 37 With and without risk adjustment, even severe obesity (class III obese group) was not found to be associated with increased rates of pneumonia, ICU readmission, in-hospital mortality, 30-day mortality, and surgical mortality or increased total ICU hours. Although some may postulate that this could be due to the lack of BMI's definition to differentiate between body fat and lean mass, 38 there is no reasonable and definite explanation for these surprising and contradictory results in both this study and the most recent research. 39 
Study Limitations
Limitations of this study included all those inherent in any retrospective analysis. To minimize this, the authors performed the data analysis with appropriate risk-adjusted statistical models to adjust for differences in preoperative risk factors. BMI was used as a measure of obesity in this study because it continued to be the most widely used anthropometric measure to quantify adiposity. However, BMI has certain inherent limitations, including not being able to identify differences in body composition and distribution of body fat. 40 BMI also does not quantify visceral adipose tissue, which may be the cornerstone in the obesity-associated pathophysiologic processes. It is possible to skew the results if BMI is used as the sole measure of obesity without adjusting for the other indices of adiposity (eg, waist-to-hip ratios, quantification of visceral fat mass). Unfortunately, this study contained data from only 2 hospitals, and therefore the data may not be generalizable, which could change some of the observed outcomes that resulted in variability among different studies.
CONCLUSIONS
In conclusion, the results of this study demonstrated that patients undergoing cardiac surgery who were either extremely obese or underweight experienced significantly higher risks associated with early major adverse clinic outcomes. However, patients who were either mildly obese or overweight experienced improved in-hospital mortality, surgical mortality, and total ICU hours, which support the presence of an obesity paradox for cardiac surgery. Despite this finding, the presence of the obesity paradox needs to be confirmed by larger, multiple-center surgical experiences before definitive recommendations are made regarding the utility of BMI measurements in preoperative risk assessments.
